Sarepta Therapeutics, Inc. SRPT Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s earnings yield?
- Sarepta Therapeutics, Inc. (SRPT) reported earnings yield of -4% in Q1 2025.
- How has Sarepta Therapeutics, Inc.'s earnings yield changed year-over-year?
- Sarepta Therapeutics, Inc.'s earnings yield decreased by 1597.5% year-over-year, from -0.2% to -4%.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s earnings yield?
- Over 4 years (2020 to 2024), Sarepta Therapeutics, Inc.'s earnings yield has grown at a -16.1% compound annual growth rate (CAGR), from -4.1% to 2%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.